Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Observational Prospective Study on Quality of Life (QOL) in Advanced Cancer Patients With Opioid-induced Constipation (OIC) Treated at Home With Naloxegol According to the Clinical Practice

NCT04294550 is registered in ClinicalTrials.gov with Fondazione ANT Franco Pannuti ETS as lead sponsor.

NCT NCT04294550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04294550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Observational Prospective Study on Quality of Life (QOL) in Advanced Cancer Patients With Opioid-induced Constipation (OIC) Treated at Home With Naloxegol According to the Clinical Practice
Lead sponsor
Fondazione ANT Franco Pannuti ETS
Phase
Observational
Overall status
Completed
Start date
September 1, 2018
Completion date
March 31, 2021
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, constipation drug induced, opioid use